Aleva Neurotherapeutics is a startup based in Switzerland.
Based in Switzerland, Aleva Neurotherapeutics is a startup.
Aleva Neurotherapeutics designs, manufactures and commercialises directional deep brain stimulation (DBS) systems, including the directSTIM™ system with a 24‑contact directional lead and MICC generator, for the treatment of Parkinson’s disease and essential tremor. The company develops medical devices and provides clinical training and support to neurologists and neurosurgeons.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.